🇺🇸 calcipotriol in United States

1,397 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Psoriasis — 341 reports (24.41%)
  2. Drug Ineffective — 242 reports (17.32%)
  3. Psoriatic Arthropathy — 127 reports (9.09%)
  4. Pruritus — 126 reports (9.02%)
  5. Malaise — 108 reports (7.73%)
  6. Pain — 102 reports (7.3%)
  7. Nausea — 95 reports (6.8%)
  8. Pneumonia — 88 reports (6.3%)
  9. Diarrhoea — 87 reports (6.23%)
  10. Hypertension — 81 reports (5.8%)

Source database →

calcipotriol in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United States

Frequently asked questions

Is calcipotriol approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for calcipotriol in United States?

NeoStrata Company, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.